Mitsubishi UFJ Asset Management Co. Ltd. Has $4.55 Million Stock Holdings in DaVita Inc. $DVA

Mitsubishi UFJ Asset Management Co. Ltd. cut its stake in shares of DaVita Inc. (NYSE:DVA) by 40.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 39,735 shares of the company’s stock after selling 27,013 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in DaVita were worth $4,550,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Elevation Wealth Partners LLC boosted its position in DaVita by 147.3% during the fourth quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock valued at $31,000 after purchasing an additional 165 shares during the last quarter. Canada Pension Plan Investment Board acquired a new position in DaVita during the second quarter valued at approximately $43,000. iSAM Funds UK Ltd acquired a new position in DaVita during the third quarter valued at approximately $46,000. Stance Capital LLC acquired a new position in DaVita during the third quarter valued at approximately $47,000. Finally, Camelot Portfolios LLC acquired a new position in DaVita during the fourth quarter valued at approximately $57,000. 90.12% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

DVA has been the subject of several recent research reports. TD Cowen increased their price target on DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research report on Monday. Barclays raised their price objective on DaVita from $158.00 to $194.00 and gave the company an “equal weight” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft raised DaVita from a “hold” rating to a “buy” rating and raised their price objective for the company from $126.00 to $220.00 in a research report on Wednesday, May 6th. Zacks Research raised DaVita from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 7th. Finally, Truist Financial raised their price objective on DaVita from $158.00 to $205.00 and gave the company a “hold” rating in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $199.17.

DaVita Stock Up 0.1%

DVA opened at $198.87 on Tuesday. DaVita Inc. has a 12-month low of $101.00 and a 12-month high of $202.13. The stock has a market cap of $12.77 billion, a price-to-earnings ratio of 18.45, a PEG ratio of 0.65 and a beta of 0.84. The business has a 50 day moving average of $154.92 and a 200-day moving average of $133.69.

DaVita (NYSE:DVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. The company had revenue of $3.42 billion during the quarter, compared to analysts’ expectations of $3.36 billion. DaVita had a negative return on equity of 270.37% and a net margin of 5.65%.The business’s revenue was up 6.0% on a year-over-year basis. During the same period last year, the firm posted $2.00 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, analysts expect that DaVita Inc. will post 15.07 earnings per share for the current year.

Insider Buying and Selling at DaVita

In other news, CFO Joel Ackerman sold 51,471 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the transaction, the chief financial officer owned 132,434 shares in the company, valued at approximately $25,440,571.40. This trade represents a 27.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.50% of the company’s stock.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.